particularly in cardiovascular complications associated with kidney disease and atherosclerosis. For example, they have ...

This includes cancer, neurological disorders, and cardiovascular diseases. The review emphasizes ... the use of nanomaterials to deliver miRNA corresponding to METTL family mRNA.

including cardiovascular diseases, tumours, chronic inflammation and pulmonary fibrosis 8. Cross-kingdom miRNA transfer may be a conserved and universal phenomenon that involves many complex ...

"The ability of PrimeC to affect miRNA expression and the underlying disease pathways not only validates our approach but positions PrimeC as a promising therapeutic candidate for ALS." Consistent ...